Tag: EMA
University of Tartu (Estonian Biobank) Joins DARWIN EU® Network to Support Europe’s Public Health,...
The European Medicines Agency (EMA) has chosen the University of Tartu as one of the data partners for the DARWIN EU® network. This partnership marks the beginning of a collaborative effort to utilize health data across Europe, with the...
DARWIN EU® Welcomes European Medicines Agency (EMA) Selected First Data Partners to Generate Real-World...
EMA has selected the first set of data partners to collaborate with DARWIN EU®, the Data Analysis and Real-World Interrogation Network. The data available to these partners will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making....
Sigilon Therapeutics’ Lead Cell Therapy Product Granted ATMP Designation By EMA
Sigilon Therapeutics is an early stage (preclinical) biotechnology company developing an encapsulated cell therapy technology. Its Afibromer™ Living Therapeutic candidate SIG-003 has been granted an Advanced Therapy Medicinal Product (ATMP) designation by the Committee for Advanced Therapies of the...
